Steele Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,288
Closed -$403K 80
2024
Q2
$403K Hold
1,288
0.02% 116
2024
Q1
$366K Buy
1,288
+257
+25% +$75.2K 0.02% 119
2023
Q4
$297K Buy
+1,031
New +$281K 0.02% 128

Other funds holding AMGN

Steele Capital Management's AMGN Position: Q3 2024 in Review

Steele Capital Management sold out of Amgen (AMGN) in Q3 2024, closing a stake of 1,288 shares — an estimated $403K sold.

Steele Capital Management first reported a position in AMGN in Q4 2023 and held it in 3 quarters. The position peaked at $403K in Q2 2024. 2,824 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • Steele Capital Management reported no remaining Amgen position as of Q3 2024 after selling out during the quarter.
  • Steele Capital Management sold 1,288 Amgen shares in Q3 2024, an estimated $403K.
  • Steele Capital Management first reported a position in Amgen in Q4 2023 and held it in 3 quarters.
  • Steele Capital Management's Amgen position peaked at $403K in Q2 2024.
  • 2,824 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Steele Capital Management's 13F filing for Q3 2024, filed 8 Nov 2024.